milestone scientific has developed and currently manufactures, markets and sells “computer-controlled local anesthetic delivery” (c-clad) systems for the improved and painless delivery of local anesthetic. the system is marketed in dentistry under the trademarks compudent & sta system (newest technology). sta™ system is suitable for all dental procedures. compudent™ and the more advanced sta™ system are suitable for all dental injections regularly used in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, orthopedics and a number of other disciplines. compudent and the sta system is sold in the united states and worldwide in over 25 countries.
Company profile
Ticker
MLSS
Exchange
Website
CEO
Leonard A. Osser
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
Former names
MILESTONE SCIENTIFIC INC/NJ, U S OPPORTUNITY SEARCH INC
SEC CIK
Corporate docs
Subsidiaries
Wand Dental , Inc. • Milestone Innovations Inc. ...
IRS number
133545623
MLSS stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
9 Apr 24
10-K
2023 FY
Annual report
29 Mar 24
8-K
Entry into a Material Definitive Agreement
12 Jan 24
8-K
Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock
12 Dec 23
424B5
Prospectus supplement for primary offering
12 Dec 23
424B5
Prospectus supplement for primary offering
8 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
EFFECT
Notice of effectiveness
31 Oct 23
CORRESP
Correspondence with SEC
26 Oct 23
UPLOAD
Letter from SEC
26 Oct 23
Transcripts
MLSS
Earnings call transcript
2023 Q3
15 Nov 23
MLSS
Earnings call transcript
2023 Q2
15 Aug 23
MLSS
Earnings call transcript
2023 Q1
10 May 23
MLSS
Earnings call transcript
2022 Q4
31 Mar 23
MLSS
Earnings call transcript
2022 Q3
15 Nov 22
MLSS
Earnings call transcript
2022 Q2
16 Aug 22
MLSS
Earnings call transcript
2022 Q1
17 May 22
MLSS
Earnings call transcript
2021 Q4
1 Apr 22
MLSS
Earnings call transcript
2021 Q3
15 Nov 21
MLSS
Earnings call transcript
2021 Q2
16 Aug 21
Latest ownership filings
4
NEAL I GOLDMAN
23 Apr 24
4
NEAL I GOLDMAN
22 Apr 24
4
NEAL I GOLDMAN
13 Dec 23
4
Giandomenico Trombetta
23 Oct 23
4
Giandomenico Trombetta
19 Oct 23
144
Notice of proposed sale of securities
17 Oct 23
4
Peter J Milligan
10 Aug 23
4
Jan Adriaan Haverhals
10 Aug 23
4
LEONARD OSSER
10 Aug 23
4
Giandomenico Trombetta
10 Aug 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.17 mm | 2.17 mm | 2.17 mm | 2.17 mm | 2.17 mm | 2.17 mm |
Cash burn (monthly) | 510.29 k | 636.76 k | 502.24 k | 595.13 k | 351.07 k | 430.83 k |
Cash used (since last report) | 3.52 mm | 4.39 mm | 3.47 mm | 4.11 mm | 2.42 mm | 2.97 mm |
Cash remaining | -1.35 mm | -2.22 mm | -1.30 mm | -1.94 mm | -252.02 k | -802.44 k |
Runway (months of cash) | -2.6 | -3.5 | -2.6 | -3.3 | -0.7 | -1.9 |
Institutional ownership, Q2 2023
5.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 30 |
Opened positions | 7 |
Closed positions | 3 |
Increased positions | 5 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 3.57 bn |
Total shares | 4.12 mm |
Total puts | 0.00 |
Total calls | 400.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 2.14 mm | $1.87 bn |
Bridgeway Capital Management | 526.70 k | $458.49 mm |
Geode Capital Management | 413.99 k | $360.38 mm |
Millennium Management | 234.77 k | $204.37 mm |
Mariner | 121.75 k | $105.98 mm |
STT State Street | 111.59 k | $97.14 mm |
NTRS Northern Trust | 95.19 k | $82.87 mm |
BLK Blackrock | 92.33 k | $80.37 mm |
Citadel Advisors | 89.74 k | $78.12 mm |
Sequoia Financial Advisors | 56.52 k | $49.20 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Apr 24 | Goldman Neal I | Common Stock, Par Value $0.001 | Grant | Acquire A | No | No | 0.55 | 22,127 | 12.17 k | 1,771,026 |
22 Apr 24 | Goldman Neal I | Common Stock, Par Value $0.001 | Grant | Acquire A | No | No | 0.54 | 56,065 | 30.28 k | 1,748,899 |
11 Dec 23 | Goldman Neal I | Common Stock, Par Value $0.001 | Grant | Acquire A | No | No | 0.63 | 125,000 | 78.75 k | 1,692,834 |
23 Oct 23 | Giandomenico Trombetta | Common Stock, Par Value $0.001 | Sale back to company | Dispose D | No | No | 0.97 | 1,400 | 1.36 k | 10,306,026 |
19 Oct 23 | Giandomenico Trombetta | Common Stock, Par Value $0.001 | Sale back to company | Dispose D | No | No | 0.95 | 2,000 | 1.90 k | 10,307,426 |
19 Oct 23 | Giandomenico Trombetta | Common Stock, Par Value $0.001 | Sale back to company | Dispose D | No | No | 0.95 | 18,600 | 17.67 k | 10,309,426 |
18 Oct 23 | Giandomenico Trombetta | Common Stock, Par Value $0.001 | Sale back to company | Dispose D | No | No | 0.92 | 3,000 | 2.76 k | 10,328,026 |
Press releases
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
3 Apr 24
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians
14 Mar 24
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio
28 Feb 24